About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

WITHDRAWNPhase 1NCT04106076

Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid Leukemia

This is a Phase I, open-label, dose escalation study of UCART123 administered intravenously to patients with newly diagnosed CD123 positive adverse genetic risk acute myeloid leukaemia (AML) defined i...

Lead sponsor: Cellectis S.A.•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Cellectis S.A.

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients newly diagnosed with CD123 positive adverse genetic risk acute myeloid leukaemia (AML) defined as per ELN guidelines (Döhner et al., 2017)
•Eastern Cooperative Oncology Group performance status of 0 or 1
•No prior gene or experimental cellular therapy
•No organ dysfunction that in the opinion of the investigator precludes intensive induction chemotherapy or cellular therapy

Related studies

Leukemia Adapted Protocol

NCT06928909 · Acute Myeloid Leukaemia

RECRUITINGPhase 1/2

A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

NCT07148180 · Acute Myeloid Leukaemia (AML), Leukemia, and more

RECRUITINGPhase 1

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

NCT05534620 · Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), and more

RECRUITINGPhase 3

MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT06345365 · Acute Myeloid Leukaemia

RECRUITINGPhase 3

International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia

NCT02724163 · Acute Myeloid Leukaemia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 14, 2020Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE1

Enrollment—

Start dateJul 2019

Last updatedJul 14, 2020

Condition

Acute Myeloid Leukaemia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 14, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions